Locquet, M., Beaudart, C., Pétermans, J., Reginster, J., & Bruyère, O. (2019). EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences.
芝加哥风格引文Locquet, Médéa, Charlotte Beaudart, Jean Pétermans, Jean‐Yves Reginster, 与 Olivier Bruyère. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
MLA引文Locquet, Médéa, et al. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
警告：这些引文格式不一定是100％准确.